Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 1 7Phase 1/2 5Phase 3 4Phase NA 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Pancreatic Neoplasms 4Colorectal Neoplasms 2Resectable Pancreatic Cancer 1Rectal Neoplasms 1Pancreatic Cancer Non-resectable 1Pancreatic Cancer Metastatic 1

Interventions

Gemcitabine 74Fluorouracil 31Oxaliplatin 21Leucovorin 21130-nm albumin-bound paclitaxel 17Capecitabine 14Irinotecan 12Albumin-Bound Paclitaxel 10irinotecan sucrosofate 8Radiotherapy 6Taxes 5Erlotinib Hydrochloride 5folfirinox 4rubitecan 3Surgical Procedures, Operative 3Specimen Handling 3Pancreaticojejunostomy 3Neoadjuvant Therapy 3Drug Therapy 3Cisplatin 3Chemotherapy, Adjuvant 3ruxolitinib 2masitinib 2dehydroftorafur 2Saline Solution 2S 1 (combination) 2Paclitaxel 2GV1001 peptide 2Fentanyl 2Bevacizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Pancreatic Neoplasms × folfirinox × Clear all
NCT06714604 2024-12-03

ADVANTAGE

Sahlgrenska University Hospital

Phase 3 Recruiting
432 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01827553 2024-04-11

CONKO-007

University of Erlangen-Nürnberg Medical School

Phase 3 Completed
830 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04897854 2021-05-24

TIMEPAN

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 3 Unknown
184 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01836432 2020-05-28

PILLAR

Lumos Pharma

Phase 3 Terminated
302 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡